{"entity":{"id":"iktos","kind":"company","name":"Iktos","aka":[],"tldr":"Iktos sells artificial intelligence software that designs new drug molecules and plans how to make them, and runs robotic labs that build and test the molecules automatically.","summary":"Iktos, founded in 2016 and based in Paris, provides AI and robotics for small-molecule discovery. Makya is a generative AI software-as-a-service platform for de novo, multi-parameter optimised molecule design; Spaya is an AI retrosynthesis tool that maps target compounds back to commercially available starting materials; and Iktos Robotics operates autonomous synthesis, purification, analysis and imaging-based screening. The company reports more than 60 collaborations with pharmaceutical, biotech and academic partners including Pfizer, Takeda and Johnson and Johnson, and has three in-house programmes: MTHFD2 (inflammation and autoimmunity, with a 2026 patent publication), amylin receptor (obesity) and SKP2-CKS1 (immuno-oncology). In 2026 it launched Iktos Engine APIs for agentic workflows and was selected for a JETRO programme in Japan. The website mentions an EIC Accelerator grant but no round amounts or investors were on fetched pages.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://iktos.ai"},{"label":"News and press","url":"https://www.iktos.ai/resources/articles"}],"tags":[],"related":[],"cancers":[],"sections":["ai-computation","drug-discovery"],"technologies":["ai-drug-design"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Series A (reported elsewhere as EUR 15.5 million) and EIC grant amount not sourced, so no round recorded."],"hq":"Paris","country":"FR","companyType":"ai-software","website":"https://iktos.ai","founded":2016,"stage":"startup","investors":[],"funding":[]},"route":"/companies/iktos/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"technology":[{"id":"ai-drug-design","kind":"technology","name":"AI-driven drug & target discovery","route":"/technologies/ai-drug-design/"}]}}